124 related articles for article (PubMed ID: 14982872)
1. Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation.
Shafarenko M; Amanullah A; Gregory B; Liebermann DA; Hoffman B
Blood; 2004 Jun; 103(11):4259-67. PubMed ID: 14982872
[TBL] [Abstract][Full Text] [Related]
2. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
[TBL] [Abstract][Full Text] [Related]
3. Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.
Gibbs JD; Liebermann DA; Hoffman B
Oncogene; 2008 Jan; 27(1):98-106. PubMed ID: 17599039
[TBL] [Abstract][Full Text] [Related]
4. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
[TBL] [Abstract][Full Text] [Related]
5. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
6. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation.
Lord KA; Abdollahi A; Hoffman-Liebermann B; Liebermann DA
Mol Cell Biol; 1993 Feb; 13(2):841-51. PubMed ID: 8423806
[TBL] [Abstract][Full Text] [Related]
7. Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation.
Shafarenko M; Liebermann DA; Hoffman B
Blood; 2005 Aug; 106(3):871-8. PubMed ID: 15840692
[TBL] [Abstract][Full Text] [Related]
8. Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells.
Takada Y; Sethi G; Sung B; Aggarwal BB
Mol Pharmacol; 2008 May; 73(5):1549-57. PubMed ID: 18287248
[TBL] [Abstract][Full Text] [Related]
9. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis.
Selvakumaran M; Liebermann D; Hoffman-Liebermann B
Blood; 1993 May; 81(9):2257-62. PubMed ID: 8481508
[TBL] [Abstract][Full Text] [Related]
10. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
Hoffman-Liebermann B; Liebermann DA
Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
[TBL] [Abstract][Full Text] [Related]
11. Terminal myeloid differentiation is uncoupled from cell cycle arrest.
Gibbs JD; Liebermann DA; Hoffman B
Cell Cycle; 2007 May; 6(10):1205-9. PubMed ID: 17495532
[TBL] [Abstract][Full Text] [Related]
12. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
[TBL] [Abstract][Full Text] [Related]
13. Leukemia suppressor function of Egr-1 is dependent on transforming oncogene.
Gibbs JD; Liebermann DA; Hoffman B
Leukemia; 2008 Oct; 22(10):1909-16. PubMed ID: 18650844
[TBL] [Abstract][Full Text] [Related]
14. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.
Selvakumaran M; Liebermann DA; Hoffman-Liebermann B
Mol Cell Biol; 1992 Jun; 12(6):2493-500. PubMed ID: 1588953
[TBL] [Abstract][Full Text] [Related]
15. The c-myc apoptotic response is not intrinsic to blocking terminal myeloid differentiation.
D'Angelo S; Liebermann D; Hoffman B
J Cell Physiol; 2008 Jul; 216(1):120-7. PubMed ID: 18247372
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
17. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
Liebermann DA; Hoffman-Liebermann B
Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
[TBL] [Abstract][Full Text] [Related]
18. Induction of proto-oncogene and cytokine expression in human peripheral blood monocytes and the monocytic cell line THP-1 after stimulation with mycoplasma-derived material MDHM.
Quentmeier H; Schumann-Kindel G; Mühlradt PF; Drexler HG
Leuk Res; 1994 May; 18(5):319-25. PubMed ID: 8182922
[TBL] [Abstract][Full Text] [Related]
19. Progression of the myeloid differentiation program is dominant to transforming growth factor-beta 1-induced apoptosis in M1 myeloid leukemic cells.
Selvakumaran M; Reed JC; Liebermann D; Hoffman B
Blood; 1994 Aug; 84(4):1036-42. PubMed ID: 8049423
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
Park S; Hahm ER; Lee DK; Yang CH
J Cell Biochem; 2004 Apr; 91(5):973-86. PubMed ID: 15034932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
